Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Gross Margin (2016 - 2026)

Cryo Cell International's Gross Margin history spans 17 years, with the latest figure at 78.44% for Q1 2026.

  • Quarterly results put Gross Margin at 78.44% for Q1 2026, up 334.0% from a year ago — trailing twelve months through Feb 2026 was 77.47% (up 168.0% YoY), and the annual figure for FY2025 was 76.63%, up 148.0%.
  • Gross Margin for Q1 2026 was 78.44% at Cryo Cell International, up from 77.89% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 79.6% in Q4 2024 to a low of 69.42% in Q3 2022.
  • The 5-year median for Gross Margin is 73.68% (2024), against an average of 74.34%.
  • The sharpest move saw Gross Margin surged 530bps in 2024, then crashed -171bps in 2025.
  • Year by year, Gross Margin stood at 72.45% in 2022, then rose by 3bps to 74.31% in 2023, then increased by 7bps to 79.6% in 2024, then fell by -2bps to 77.89% in 2025, then rose by 1bps to 78.44% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods came in at 78.44%, 77.89%, and 76.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.